Partnership--Moffitt Cancer--Puerto Rico Cancer Center

在过去的一年中，H. lee Moffitt癌症中心（HLMCC）和波多黎各癌症中心（PRCC）之间的合作关系一直在发展，并导致联合签署了一份合作协议。坦帕和圣胡安的地理位置非常接近，因此这种合作关系是合乎逻辑的。此外，这些机构中的每一个都有需要进一步发展的领域，这种特殊的机构伙伴关系提供了加强这种发展的专门知识。HLMCC服务的人群包括一个重要的西班牙裔社区。西班牙裔在癌症治疗方面服务不足，因此，HLMCC致力于提高其向佛罗里达州西班牙裔社区提供癌症治疗的能力。从PRCC获得的专业知识将有助于实现这一目标，开发一个旨在发展针对西班牙裔社区的外展和癌症教育项目。PRCC积极参与临床研究；然而，他们还没有能力进行早期化疗试验和转化研究。高级别协调委员会在这些领域拥有专门知识，将与PRCC分享。将设立的具体项目将包括临床培训项目，医学肿瘤学和血液学研究员的转化研究。此外，将为外科肿瘤学家建立淋巴测图和前哨淋巴结活检技术的培训计划。加强PRCC进行这些临床试验的能力将导致参与此类临床研究的西班牙裔医生数量的增加，并将提高西班牙裔患者在临床试验中的代表性。为了开展未来针对西班牙裔人群的转化研究，将开发一个基础研究项目，旨在识别西班牙裔癌症患者肿瘤中致癌途径的分子畸变。

The development of a partnership between the H. lee Moffitt Cancer Center (HLMCC) and the Puerto Rico Cancer Center (PRCC) has been in progress over the past year and has resulted in the joint signing of an affiliation agreement. The close geographic proximity of Tampa and San Juan made this partnership logical. In addition, each of these institutions has areas where further development is necessary, and this particular institutional partnership provides expertise to enhance this development. The HLMCC serves a population that consists of a significantg Hispanic community. Hispanics are underserved with respect to cancer care, and therefore, the HLMCC is committed to improving its ability to deliver cancer care to the Hispanic community in Florida. Expertise obtained from the PRCC will help to accomplish this goal, with the development of a project designed to develop outreach and cancer education programs which target the Hispanic community. The PRCC is active in clinical research; however, they have not yet had the capacity to perform early phase chemotherapy trials and translational research. The HLMCC has expertise in these areas which will be shared with the PRCC. The specific programs that will be set up will include a training program in clinical, translational research for medical oncology and hematology fellows. Additionally, a training program for surgical oncologists will be set up in the technique of lymphatic mapping and sentinel lymph node biopsy. An enhanced capacity of the PRCC to conduct these clinical trials will result in an increase in the number of Hispanic physicians participating in such clinical research, and will enhance the representation of Hispanic patients in clinical trials. In order to develop future translational research specifically targeting the Hispanic population, a basic research project will be developed designed to identify molecular aberrations in oncogenic pathways in tumors from Hispanic cancer patients.